Literature DB >> 8428751

Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts.

M Raghunath1, A Superti-Furga, M Godfrey, B Steinmann.   

Abstract

Abnormalities of the microfibrillar protein fibrillin (Fib) have been reported in Marfan syndrome (MFS). The so-called neonatal Marfan syndrome (nMFS) is a lethal phenotype displaying features that are not seen in classical MFS. We have therefore studied the biosynthesis and extracellular deposition of Fib and decorin in fibroblasts from a patient with nMFS and controls. Immunofluorescence of the patient's cell cultures showed an almost complete absence of Fib and a marked reduction of decorin in the extracellular matrix (ECM). The nMFS skin revealed Fib on subbasal microfibrillar bundles in the papillary dermis, and Fib associated with elastic fibers in the reticular dermis; the bundles and fibers were fragmented and thinner than normal. Pulse-chase labeling of cells with [35S]Met/Cys revealed moderately reduced secretion, but a diminished deposition of Fib in the ECM; this was more apparent at a longer chase time. Fib mRNA and synthesis appeared to be normal, whereas both decorin mRNA and biosynthesis were reduced. We therefore assume a structural Fib defect in this patient causing reduced deposition into and/or enhanced removal from the ECM, whereas the reduced decorin biosynthesis may be a secondary regulatory phenomenon. The clinical relevance of this remains unclear. Our findings imply that Fib defects may be responsible for the severe, complex phenotype of nMFS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428751     DOI: 10.1007/bf00217450

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

1.  Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts.

Authors:  D M Milewicz; R E Pyeritz; E S Crawford; P H Byers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.

Authors:  H C Dietz; G R Cutting; R E Pyeritz; C L Maslen; L Y Sakai; G M Corson; E G Puffenberger; A Hamosh; E J Nanthakumar; S M Curristin
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

3.  Partial sequence of a candidate gene for the Marfan syndrome.

Authors:  C L Maslen; G M Corson; B K Maddox; R W Glanville; L Y Sakai
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Congenital contractural arachnodactyly. A heritable disorder of connective tissue.

Authors:  R K Beals; F Hecht
Journal:  J Bone Joint Surg Am       Date:  1971-07       Impact factor: 5.284

6.  Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome.

Authors:  L Pulkkinen; K Kainulainen; T Krusius; P Mäkinen; J Schollin; K H Gustavsson; L Peltonen
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

7.  Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome.

Authors:  M Godfrey; S Olson; R G Burgio; A Martini; M Valli; G Cetta; H Hori; D W Hollister
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

8.  Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1.

Authors:  R E Magenis; C L Maslen; L Smith; L Allen; L Y Sakai
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

9.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.

Authors:  B Lee; M Godfrey; E Vitale; H Hori; M G Mattei; M Sarfarazi; P Tsipouras; F Ramirez; D W Hollister
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

10.  Recurrent ctb(7)(q31.3) and possible laminin involvement in a neonatal cutis laxa with a Marfan phenotype.

Authors:  D Bonneau; J L Huret; G Godeau; D Couet; M Putterman; J Tanzer; P Babin; M Larrègue
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

View more
  13 in total

Review 1.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

2.  Abnormal morphology of fibrillin microfibrils in fibroblast cultures from patients with neonatal Marfan syndrome.

Authors:  M Godfrey; M Raghunath; J Cisler; C L Bevins; A DePaepe; M Di Rocco; J Gregoritch; K Imaizumi; P Kaplan; Y Kuroki
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

3.  Classical and neonatal Marfan syndrome mutations in fibrillin-1 cause differential protease susceptibilities and protein function.

Authors:  Ryan Kirschner; Dirk Hubmacher; Garud Iyengar; Jasvir Kaur; Christine Fagotto-Kaufmann; Dieter Brömme; Rainer Bartels; Dieter P Reinhardt
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

4.  Early fibrillin-1 assembly monitored through a modifiable recombinant cell approach.

Authors:  Dirk Hubmacher; Eric Bergeron; Christine Fagotto-Kaufmann; Lynn Y Sakai; Dieter P Reinhardt
Journal:  Biomacromolecules       Date:  2014-03-07       Impact factor: 6.988

5.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injury.

Authors:  Liliana Schaefer; Daniel Mihalik; Andrea Babelova; Miroslava Krzyzankova; Hermann-Josef Gröne; Renato V Iozzo; Marian F Young; Daniela G Seidler; Guoqing Lin; Dieter P Reinhardt; Roland M Schaefer
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 7.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

8.  A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype.

Authors:  L Karttunen; M Raghunath; L Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

9.  Analyses of truncated fibrillin caused by a 366 bp deletion in the FBN1 gene resulting in Marfan syndrome.

Authors:  M Raghunath; C M Kielty; K Kainulainen; A Child; L Peltonen; B Steinmann
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

10.  Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15.

Authors:  D M Milewicz; M Duvic
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.